Q4 2022 Holdings
Filed 2023-02-14 | 120 holdings | $4.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Humana Inc(HUM) | COM | 444859102 | $218.4M | 426,500 | 5.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $189.5M | 3,321,066 | 4.6% |
| Insulet Corp(PODD) | COM | 45784P101 | $154.3M | 524,250 | 3.7% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $143.1M | 270,000 | 3.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $134.1M | 1,122,500 | 3.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $132.6M | 350,000 | 3.2% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $127.1M | 7,872,500 | 3.1% |
| Prometheus Biosciences Inc | COM | 74349U108 | $113.5M | 1,031,550 | 2.7% |
| Penumbra Inc(PEN) | COM | 70975L107 | $113.1M | 508,250 | 2.7% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $106.8M | 3,803,500 | 2.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $101.0M | 348,121 | 2.4% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $84.7M | 207,500 | 2.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $84.2M | 739,700 | 2.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $84.1M | 2,996,592 | 2.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $82.9M | 1,891,510 | 2.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $81.3M | 413,762 | 2.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $79.2M | 298,500 | 1.9% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $79.1M | 2,506,464 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $79.0M | 332,500 | 1.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $76.8M | 1,400,654 | 1.8% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $69.6M | 845,500 | 1.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $63.8M | 302,350 | 1.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $62.4M | 3,961,249 | 1.5% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $59.8M | 1,290,279 | 1.4% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $58.6M | 1,150,000 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $56.5M | 436,000 | 1.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $55.5M | 490,500 | 1.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $52.0M | 425,500 | 1.3% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $51.4M | 400,200 | 1.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $51.3M | 1,760,865 | 1.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $48.2M | 645,900 | 1.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $46.4M | 1,175,672 | 1.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $45.4M | 1,229,637 | 1.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $45.4M | 753,462 | 1.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $43.9M | 887,500 | 1.1% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $43.7M | 185,500 | 1.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $42.7M | 1,077,900 | 1.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $42.1M | 1,302,500 | 1.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $39.9M | 1,032,600 | 1.0% |
| Olink Hldg AB | SPONSORED ADS | 680710100 | $36.7M | 1,445,000 | 0.9% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $36.5M | 805,024 | 0.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $35.0M | 1,795,733 | 0.8% |
| Freshpet Inc(FRPT) | COM | 358039105 | $34.7M | 657,000 | 0.8% |
| Abcam PLC | ADS | 000380204 | $33.9M | 2,180,000 | 0.8% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $32.5M | 1,059,700 | 0.8% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $30.6M | 1,227,779 | 0.7% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $29.0M | 309,450 | 0.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $27.4M | 264,500 | 0.7% |
| Select Sector Spdr TR(XLV) | SBI HEALTHCARE | 81369Y209 | $27.2M | 200,000 | 0.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $26.8M | 5,333,188 | 0.6% |